Immusant Inc Headquarters
The links below provide all the necessary information about Immusant Inc Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
ImmusanT Company Profile - Craft
- https://craft.co/immusant
- ImmusanT is headquartered in Cambridge, United States All Locations (1) Key People/Management at ImmusanT Leslie Williams Director, Founder, President and Chief Executive Officer Tom Shea Chief Financial Officer Kevin Ferro Director Joyce Pinkham Vice President, Program Management Steven Gillis Managing Director Justin Sun
ImmusanT - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/immusant
- Where is ImmusanT 's headquarters? ImmusanT is located in Cambridge, Massachusetts, United States. Who invested in ImmusanT? ImmusanT has 3 investors including JDRF T1D Fund and ARCH Venture Partners. How much funding has ImmusanT raised to date? ImmusanT has raised $72.8M. When was the last funding round for ImmusanT?
ImmusanT Inc. - Company Profiles - BCIQ
- https://profiles.biocentury.com/companies/immusant_inc
- You are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. REQUEST A FREE TRIAL. Overview. Pipeline. Deals. Financings. Articles. ImmusanT Inc. Headquarters: Cambridge, MA.
ImmusanT Company Profile: Valuation & Investors
- https://pitchbook.com/profiles/company/53480-71
- Contact Information Website www.immusant.com Ownership Status Out of Business Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office One Kendall Square Building 700 Cambridge, MA 02139 United States Want detailed data on 3M+ companies? What you see here scratches the surface
ImmusanT Inc - Company Profile and News - Bloomberg …
- https://www.bloomberg.com/profile/company/0102608D:US
- Company profile page for ImmusanT Inc including stock price, company news, press releases, executives, board members, and contact information
Immunant Inc - Company Profile and News - Bloomberg …
- https://www.bloomberg.com/profile/company/1328475D:US
- Company profile page for Immunant Inc including stock price, company news, press releases, executives, board members, and contact information
ImmusanT | VentureRadar
- https://www.ventureradar.com/organisation/ImmusanT/7d286e7e-9de2-432a-9c1c-613c1443007d
- ImmusanT is a privately held biotechnology company focused on protecting patients with celiac disease against the effects of gluten. By harnessing new discoveries in immunology, ImmusanT aims to improve diagnosis and medical management of celiac disease by protecting against the effects of gluten exposure while patients maintain a gluten-free ...
ImmusanT 1 Kendall Sq Cambridge, MA Medical Centers
- https://www.mapquest.com/us/massachusetts/immusant-284772103
- United States › Massachusetts › Cambridge › ImmusanT. ImmusanT. 1 Kendall Sq, Cambridge, MA 02139. (617) 299-8399. Claim this business. (617) 299-8399. Favorite.
ImmusanT drug trial fails in mid-stage trial - Boston …
- https://www.bizjournals.com/boston/news/2019/07/01/expert-calls-immunsant-celiac-drug-trial-failure.html
- Jul 1, 2019 Six months ago, biotech startup ImmusanT Inc. was toasting its new headquarters, an expanded space in Kendall Square to accommodate its growth plans as its celiac disease drug candidate...
About Us :: Immunovant, Inc. (IMVT)
- https://www.immunovant.com/about-us
- About Us. Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases. Immunovant is developing IMVT-1401 (“batoclimab”), a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG ...
ImmusanT Raises $40 Million in Series C Financing - MTS Partners
- https://www.mtspartners.com/news/immusant-raises-40-million-in-series-c-financing/
- CAMBRIDGE, Mass. – November 14, 2017 – ImmusanT, Inc., a clinical-stage company developing Nexvax2®, a therapeutic vaccine designed to induce immune tolerance in celiac disease, today announced the completion of a $40 million Series C equity financing from ARCH Venture Partners and Vatera Healthcare Partners. The proceeds will fund a ...
ImmusanT Raises $20 Million in Series A Financing to Advance ...
- https://www.prnewswire.com/news-releases/immusant-raises-20-million-in-series-a-financing-to-advance-immunotherapeutic-and-diagnostic-for-celiac-disease-135496313.html
- CAMBRIDGE, Mass., Dec. 13, 2011 /PRNewswire/ -- ImmusanT, Inc. announced today it has raised $20 million in Series A financing from Vatera Healthcare Partners LLC to advance development of the ...
Immunant, Inc
- https://immunant.com/
- Immunant, Inc. homepage > Immunant. Blog; Contact; Jobs; Migration; We Improve Systems Software. Immunant is a leading systems software consultancy. The most privileged layers in the software stack are not as secure or reliable as we'd like. It doesn't have to be that way! We do high-impact applied research and development such as:
Contact Us :: Immunant, Inc
- https://immunant.com/contact/
- Send Message. © 2021 Immunant, Inc. Immunant, Inc.
Comporium - Overview, News & Competitors | ZoomInfo.com
- https://www.zoominfo.com/c/comporium-inc/9143003
- Founded in 1894, Comporium Communications is a local telephone, internet, cable and home security provider that centrally operates in York and Lancaster countie. s in the north-central section of South Carolina. Read More. Headquarters: 332 Black St E, Rock Hill, South Carolina, 29730, United States.
Did you find out everything you wanted about Immusant Inc Headquarters?
We are sure that the information collected for you about Immusant Inc Headquarters turned out to be more than enough.
